[Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
D000135:Acid Phosphatase / Q000032:analysis*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005293:Ferritins / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000032:analysis*; D029584:Prostatic Secretory Proteins; D011506:Proteins / Q000032:analysis*; D029589:Seminal Plasma Proteins; D019396:Tissue Polypeptide Antigen; D014565:Urogenital Neoplasms / Q000175:diagnosis*; D000509:alpha-Fetoproteins / Q000032:analysis*
D002272:Carcinoembryonic Antigen; D010455:Peptides; D029584:Prostatic Secretory Proteins; D011506:Proteins; D029589:Seminal Plasma Proteins; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins; C043076:beta-microseminoprotein; D005293:Ferritins; D000135:Acid Phosphatase